Skip to main content

Table 1 Patients’ characteristics

From: Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study

Characteristic Patients (n = 25)
Age (years), median (range) 66 (51–80)
Tumor size (mm), median (range) 28 (12–40)
Sex, n (%)
 Male 16 (64.0)
 Female 9 (36.0)
Primary tumor location, n (%)
 Head/neck 18 (72.0)
 Body 6 (24.0)
 Tail 1 (4.0)
NCCN resectability, n (%)
 Resectable 17 (68.0)
 Borderline resectable 8 (32.0)
  BR-PV 6 (24.0)
  BR-A 2 (8.0)
Completion of NACRT, n (%) 23 (92.0)
Completion of RT, n (%) 25 (100.0)
Completion of CT, n (%) 23 (92.0)
Resection rate, n (%) 17 (68.0)
Reason for protocol failure, n (%)
 Cholangitis 1 (4.0)
 Neutropenia 1 (4.0)
  1. Abbreviations: CT chemotherapy, NACRT neoadjuvant chemoradiotherapy, NCCN National Comprehensive Cancer Network, BR-PV borderline resectable-portal vein, BR-A borderline resectable-artery, RT radiotherapy